Contents
Contents
Medical device free equipment kickbacks use equipment, loaners or operating support to induce purchases that lead to government-paid claims. The benefit can be a surgical instrument set, a machine in a physician’s private practice or a call center doing a supplier’s patient outreach. The commercial bargain sits behind the free offer: whose expense the manufacturer picks up, and whose business it expects in return.
The Anti-Kickback Statute reaches value offered to induce purchases or recommendations of products paid for by federal health care programs. When claims result from that conduct, the False Claims Act provides a route to recover government money. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.
For a device sales representative, product specialist or purchasing employee, the revealing detail may be the condition attached to the support. The grant waits for a purchase. The service becomes expensive when patients use a competitor’s product. The free equipment goes to someone who influences a different institution’s orders.
Medicare usually pays for an implanted device through the hospital’s procedure or inpatient stay payment. The surgeon may choose the implant, the hospital buys it, and the hospital bills for the care. The person receiving a manufacturer’s benefit and the institution submitting the claim can be different participants in the same transaction.
The Department of Health and Human Services’ inspector general describes implantable devices as physician preference items: physicians can strongly influence both the brand and the type selected. That gives a manufacturer a reason to direct a benefit toward the surgeon even though purchasing handles the invoice.
A hospital bill can show the device separately even though Medicare includes its cost in the payment for the procedure.
Durable medical equipment follows a different commercial path in the sleep-apnea cases. The manufacturer supplies masks and equipment to a supplier that serves patients, and the resulting claims reach programs such as Medicare and Medicaid. Free patient outreach can help that supplier generate resupply orders. Here, the recipient of the operating support is also the business whose patient orders lead to the claims.
Free equipment can influence hospital purchases even when a physician uses it somewhere else. DePuy Synthes and Olympus show how the location of the benefit can differ from the location of the business it buys.
Free implants for overseas surgeries led to a January 2023 civil settlement of $9.75 million for DePuy Synthes. The company admitted that former sales representatives gave a Massachusetts surgeon free implants and instruments for overseas surgeries. The products included cages, rods, screws, plates and surgical instruments.
The patients abroad were not federal health care beneficiaries. The government’s allegation concerned the surgeon’s choice of DePuy products for Medicare and Medicaid patients in Massachusetts. The overseas operations supplied the benefit. The domestic product choices supplied the alleged return.
That distinction matters to someone handling a free-product request. The destination on the shipping paperwork may explain where the equipment went. The surgeon’s purchasing influence explains why the manufacturer wanted to provide it.
Olympus Corporation of the Americas admitted the truth of the criminal complaint describing kickbacks to doctors and hospitals. As the Justice Department’s account of that criminal complaint explains, a physician with a major role in a New York medical center’s purchasing decisions received free use of $400,000 in equipment for his private practice.
The same admitted account described a $5,000 hospital grant intended to facilitate a $750,000 sale. Olympus also held up a research grant until another hospital signed an equipment purchase deal. The timing made the bargain visible: the research money waited for the order.
The whistleblower’s separate civil complaint alleged that the equipment arrangements wore ordinary commercial labels:
Olympus routinely provides kickbacks to hospitals in the form of free products or the free use of equipment, disguised in the form of discounts or equipment loans.
United States ex rel. Slowik v. Olympus America Inc., whistleblower complaint, paragraph 97
The equipment loans and grants were part of a broader kickback case that Olympus resolved with a $310.8 million civil False Claims Act settlement.
A free sleep-apnea call center can subsidize a supplier’s operating costs while steering its mask purchases. Equipment, installation and financing can serve the same sales objective through different parts of the customer’s business.
Respironics allegedly supplied patient resupply call-center services without charge when patients used its masks. Under the alleged arrangement, suppliers serving patients using a competitor’s masks had to pay a monthly fee based on the number of those patients. The 2016 settlement announcement tied the allegations to claims to Medicare, Medicaid and TRICARE.
Under the pricing alleged by the Justice Department, choosing a competitor’s mask meant paying for outreach that Respironics mask users received free. The alleged benefit sat in the cost of serving patients, alongside the price of the mask itself.
The allegedly free service led to a $34.8 million settlement for Respironics.
Free services, equipment and supplier financing were at the center of ResMed’s January 2020 civil settlement of more than $37.5 million. The allegations covered several distinct benefits:
The financing allegation reaches a different set of records from a free-device shipment. A financial institution supplied the loan, while ResMed allegedly stood behind repayment. The benefit was access to credit on those terms. The lender’s agreement and the manufacturer’s undertaking explain that arrangement.
Taken together, the allegations follow the business from testing and equipment acquisition to repeat supply orders. Sales support can reach the sleep lab, the physician and the supplier through separate agreements.
Covidien, Merit Medical Systems and Cardiovascular Systems allegedly used practice marketing support to induce purchases of their devices.
EBI, doing business as Biomet Spine and Bone Healing Technologies, allegedly paid doctors’ office staff to influence orders for bone-growth stimulators. The Justice Department’s account described payments through personal-service agreements with staff members.
The alleged recipient was the employee positioned to influence the doctor’s order. Staff agreements, payment records and the order workflow belong beside the physician’s product use when examining that arrangement.
An equipment loan can buy product orders without the manufacturer ever giving up ownership. The Olympus complaint alleged exactly that exchange: free use of equipment disguised as a loan or discount.
Consignment puts the manufacturer’s inventory where a surgery will happen, with the sale occurring when the product is used. In the documented arrangements, the manufacturer can retain ownership while the hospital holds the stock. Delivery, implantation and payment occur at different points.
For a loaner or evaluation unit, we examine what the customer received and which purchases the manufacturer expected in return. Ownership, actual use and purchase commitments help us explain the bargain behind the placement.
The useful evidence connects the benefit, the product decision and the resulting government claim. It also shows who understood why the support was being provided.
A Forensic Accountant’s Guide to the Most Potent Federal Laws Used Against Healthcare Fraud, published in the Journal of Forensic and Investigative Accounting in 2020, explains why inside knowledge matters: complex financial fraud often cannot be detected without people who know how it works. An equipment invoice may show what arrived. The person who approved the exception may know which orders were expected in return.
Connecting the agreement, the orders and the bills is work we do with you. For an equipment placement, we examine what was delivered, where it was installed, how long it stayed and which purchases accompanied it. For a call center, we connect the service contract and brand-based charges to the resulting orders.
The commercial communications matter alongside those records. A grant held until a purchase, a fee tied to competitor use or a compliance warning left unanswered can show the purpose behind an arrangement. An insider who knows how the exception was approved can explain a decision the invoice never describes.
If you know which purchases kept the equipment or support flowing, speak with our whistleblower experts about that arrangement. We build the case with you around the benefit, the buying decision and the government claims, and bring in medical device whistleblower lawyers who understand these sales arrangements. You bring the inside view of the bargain, and we stay beside you through the case.